中医药干预超早期脑梗死静脉溶栓方案观察

Observation of TCM Intervention in super early stage of cerebral infarction thrombolytic scheme

目的：探讨中医药干预超早期脑梗死静脉溶栓治疗方案的安全性以及疗效性。方法：采用回顾性方法分析，选取我院自2011年1月～2013年1月两年以来收治的36例超早期脑梗死患者的临床资料，随机将其分为对照组以及观察组，各18例，对照组单纯采用静脉溶栓，观察组在此基础上采用中医药干预治疗。比较溶栓前、溶栓后24小时、溶栓7周以及溶栓30天的神经功能评分以及临床疗效评定。结果：两组患者的神经功能评分以及疗效上在治疗后24小时以及7天没有明显的差异，不具有差异统计学意义（P＞0.05），在治疗后30天在神经功能缺损评分以及临床疗效上有着明显的差异，具有差异统计学意义（P＜0.05）。结论：对超早期脑梗死患者在静脉溶栓治疗基础上进行中医药干预，疗效较好，安全可靠，值得临床推广。

Objective： To investigate the effect of Chinese medicine intervention treatment of hyperacute cerebral infarction thrombolysis safety and efficacy. Method：analysis by retrospective method, the clinical data of 36 cases of hyperacute cerebral infarction patients in our hospital since 2011, January-2013 year in January two years of our hospital, were randomly divided into control group and observation group, each 18 cases, the control group is treated with intravenous thrombolytic therapy, the observation group based on the use of Chinese medicine intervention treatment. Comparison of thrombolytic therapy, thrombolysis, 24 hours after thrombolysis in 7 weeks and thrombolytic therapy in 30 days the neurological function score and clinical assessment. Results： the two groups of patients with neurological function scores and curative effect in 24 hours and 7 days after treatment, no obvious difference, does not have a statistically significant difference （P〉0.05）, on the 30 day post treatment scores on neurologic impairment and clinical curative effect has obvious difference, with statistically significant difference （P〈0.05）. Conclusion：in patients with hyperacute cerebral infarction of the intervention of traditional Chinese medicine, on the basis of intravenous thrombolytic therapy on the efficacy, safety and reliability, is worth the clinical promotion.